COVID19vaccine
Pfizer just released a new statement for investors citing they’ve inked a deal with Microsoft to integrate their Pluton processor chip to reduce symptoms associated with the vaccine. In the release it is stated that receivers of the new vaccine expect reduced fatigue, reduced soreness, heightened awareness etc. Q1 2021 hedge fund letters, conferences and more Microsoft CEO Praises Pfizer's COVID-19 Vaccine UpgradeMicrosoft CEO Satya Nadella said “This is a great revolution in medicine, with the addition of Microsoft’s powerful Pluton chip, it will make tracking the data of vaccine recipients e...
ValueWalk
Drs. Diana Hendel and Mark Goulston say trauma isn’t always caused by a big “shock and awe” event. It can also happen gradually. Here are some warning signs to help you intervene before your organization sustains irreparable damage. Q4 2020 hedge fund letters, conferences and more Struggling With The Aftermath Of TraumaNashville, TN (March 2021)—While there is light at the end of the tunnel with the growing availability of the COVID-19 vaccine, times are tough all over, and many businesses are still under great strain. Given the events of this past year, if you and your employees weren’t at le...
ValueWalk
The rollout of Pfizer’s COVID-19 vaccine has had a few hiccups, but it’s going smoothly for the most part, according to Health and Human Services Secretary Alex Azar. He told CNBC that there was a “slight negative excursion” during the rollout of Pfizer’s COVID-19 vaccine. It had to do with the temperature of the vaccine doses during shipment. Q3 2020 hedge fund letters, conferences and more Temperature issues with Pfizer vaccine during rolloutGen. Gustave Perna, chief operating officer of Operation Warp Speed, told reporters that a number of trays of vials that had been delivered to Californi...
ValueWalk
A new poll about the COVID-19 vaccine indicates new comfort and enthusiasm. The percent of Americans who say they will get the injections as soon as they become available has doubled in the last three months. According to the latest poll about the COVID-19 vaccine from Axios and Ipsos, more than 25% now say they will get it as soon as they can. COVID-19 vaccine poll shows more are readyAs the first Americans receive the vaccine, it appears that more and more Americans are becoming comfortable with the idea of receiving a brand-new vaccine. According to Axios, those who are age 65 and older acc...
ValueWalk
The outlook for the gold price in 2021 is still positive, although the recent news about COVID-19 vaccines has taken a bite out of this latest brief rally. HSBC Chief Precious Metals Analyst James Steel said in a report this week that the gold price still has plenty of supports going into 2021, which is good for the outlook for the precious metal. Q3 2020 hedge fund letters, conferences and more Outlook for gold price in 2021Steel noted that the gold price hit record highs this year, driven by strong demand from both institutional and retail investors, who bought the yellow metal due to its qu...
ValueWalk
Commenting on the possible approval of Pfizer’s and Moderna’s vaccine candidate and today’s trading Gorilla Trades strategist Ken Berman said: Q3 2020 hedge fund letters, conferences and more Nasdaq Closed At An All-Time HighNasdaq closed at an all-time high yet again and even the weaker S&P 500 and Dow remain only a tad below their highs from Friday. The resilience of the major indices was impressive today, even as the recent COVID trends have been gloomy, and besides the large-cap benchmarks, the Russell 2000 also held up well, which could mean that the broad-based rally will continue this w...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら